| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006412166 |
| P356 | DOI | 10.1186/AR3260 |
| P8608 | Fatcat ID | release_r5qn5rsd2fhzdpym4qj3txissa |
| P932 | PMC publication ID | 3241376 |
| P698 | PubMed publication ID | 21345216 |
| P5875 | ResearchGate publication ID | 49942617 |
| P50 | author | Michael E Weinblatt | Q88922582 |
| Jeffrey N Katz | Q89419301 | ||
| Jennifer M Polinski | Q90730896 | ||
| Daniel H Solomon | Q91503755 | ||
| Helen Mogun | Q106512470 | ||
| P2093 | author name string | Seo Young Kim | |
| Amber Servi | |||
| P2860 | cites work | Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients | Q30813174 |
| Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis | Q37252568 | ||
| The sensitivity and specificity of computerized databases for the diagnosis of rheumatoid arthritis | Q40656532 | ||
| Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis | Q45333297 | ||
| Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification | Q47985286 | ||
| Validity of rheumatoid arthritis diagnoses listed in the Saskatchewan Hospital Separations Database | Q48571460 | ||
| Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. | Q50579456 | ||
| Rheumatoid arthritis in a medical information system: how valid is the diagnosis? | Q71015055 | ||
| Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures | Q73766154 | ||
| P433 | issue | 1 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | R32 | |
| P577 | publication date | 2011-02-23 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Validation of rheumatoid arthritis diagnoses in health care utilization data | |
| P478 | volume | 13 |
| Q30713544 | A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data |
| Q35046916 | A validation study of a new classification algorithm to identify rheumatoid arthritis using administrative health databases: case-control and cohort diagnostic accuracy studies. Results from the RECord linkage On Rheumatic Diseases study of the Ital |
| Q36019747 | Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis |
| Q37729543 | Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis |
| Q35564852 | Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. |
| Q92476178 | Barriers to treatment optimization and achievement of patients' goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry |
| Q40833429 | Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study |
| Q57058395 | Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis |
| Q46155482 | Biologic disease-modifying anti-rheumatic drugs and the risk of non-vertebral osteoporotic fractures in patients with rheumatoid arthritis aged 50 years and over |
| Q37347229 | Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014. |
| Q39744551 | Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments |
| Q38937245 | Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study |
| Q36361147 | Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs |
| Q40207494 | Chronic inflammatory arthritis prevalence estimates for children and adolescents in three Canadian provinces |
| Q49788530 | Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study |
| Q47116867 | Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis |
| Q90030667 | Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study |
| Q47318130 | DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study |
| Q36004938 | Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis |
| Q38800510 | Development and validation of case-finding algorithms for the identification of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in large healthcare administrative databases |
| Q44761440 | Development of an algorithm for identifying rheumatoid arthritis in the Korean National Health Insurance claims database |
| Q34681579 | Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study. |
| Q36573102 | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study |
| Q49835073 | Dynamic patterns and predictors of hydroxychloroquine nonadherence among Medicaid beneficiaries with systemic lupus erythematosus |
| Q37051820 | Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study. |
| Q40813632 | Epidemiology and Treatment of New-Onset and Established Rheumatoid Arthritis in an Insured US Population |
| Q54957060 | Factors associated with physicians' prescriptions for rheumatoid arthritis drugs not filled by patients. |
| Q36199089 | Identification of rheumatoid arthritis patients using an administrative database: a Veterans Affairs study. |
| Q99240931 | Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis |
| Q38844078 | Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis. |
| Q36333473 | Improving medical record retrieval for validation studies in Medicare data. |
| Q30829469 | Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research |
| Q52592135 | Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population. |
| Q39918625 | Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study |
| Q36633320 | Monitoring diabetes in patients with and without rheumatoid arthritis: a Medicare study |
| Q36291405 | No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population |
| Q39225848 | Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study |
| Q37341110 | Patients with Rheumatoid Arthritis have Similar Excellent Outcomes after Total Knee Replacement Compared with Patients with Osteoarthritis |
| Q52688337 | Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink. |
| Q37604968 | Patterns and associated risk of perioperative use of anti-tumor necrosis factor in patients with rheumatoid arthritis undergoing total knee replacement |
| Q34379235 | Patterns of disease-modifying antirheumatic drug use in rheumatoid arthritis patients after 2002: a systematic review |
| Q40355795 | Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty |
| Q36150089 | Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System |
| Q30713580 | Post-licensure rapid immunization safety monitoring program (PRISM) data characterization |
| Q33955222 | Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis |
| Q38813411 | Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. |
| Q39822865 | Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis |
| Q35695760 | Receipt of glucocorticoid monotherapy among Medicare beneficiaries with rheumatoid arthritis |
| Q34244790 | Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt |
| Q35930834 | Resource use and costs in an insured population of patients with chronic idiopathic/spontaneous urticaria |
| Q36588424 | Rheumatoid Arthritis Does Not Increase Risk of Short-term Adverse Events after Total Knee Arthroplasty: A Retrospective Case-control Study. |
| Q38779854 | Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for Vaccination |
| Q90665225 | Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study |
| Q34167722 | Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study |
| Q33877737 | Risk of venous thromboembolism in patients with rheumatoid arthritis |
| Q40091147 | Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs |
| Q38418892 | Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy |
| Q58555310 | Screening of Hyperlipidemia among Patients with Rheumatoid Arthritis in the United States |
| Q33588462 | Statin use and mortality in rheumatoid arthritis: a general population-based cohort study |
| Q88812010 | Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment |
| Q38084255 | Systematic review and critical appraisal of validation studies to identify rheumatic diseases in health administrative databases |
| Q36240514 | The Detection of Rheumatic Disease through Hospital Diagnoses with Examples of Rheumatoid Arthritis and Giant Cell Arteritis: What Are We Missing? |
| Q35131441 | The incidence of upper and lower extremity surgery for rheumatoid arthritis among Medicare beneficiaries |
| Q40284619 | The practice pattern of hepatitis b testing in rheumatoid arthritis patients: A cross-national comparison between US and Taiwan. |
| Q37446317 | The risk of atrial fibrillation in patients with rheumatoid arthritis |
| Q43488992 | The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. |
| Q35017686 | The validity of the diagnosis of inflammatory arthritis in a large population-based primary care database |
| Q40492165 | Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting |
| Q54977685 | Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population. |
| Q50919081 | Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US medicare program. |
| Q33871929 | Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. |
| Q36219817 | Use of Decision Support for Improved Knowledge, Values Clarification, and Informed Choice in Patients With Rheumatoid Arthritis |
| Q36942914 | Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients |
| Q42575985 | Use of administrative claims data for comparative effectiveness research of rheumatoid arthritis treatments |
| Q30717256 | Use of health plan combined with registry data to predict clinical trial recruitment. |
| Q92917818 | Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study |
| Q27014061 | Validation of administrative health data for the pediatric population: a scoping review |
| Q37502227 | Validity of the RAI-MDS for ascertaining diabetes and comorbid conditions in long-term care facility residents |
Search more.